The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 16, 2026

Filed:

May. 02, 2022
Applicant:

Opko Diagnostics, Llc, Woburn, MA (US);

Inventors:

Yan Dong, Medford, MA (US);

Andrew J. Vickers, Brooklyn, NY (US);

Daniel Sjoberg, New York, NY (US);

Peter T. Scardino, New York, NY (US);

Hans Lilja, New York, NY (US);

Assignee:

OPKO Diagnostics, LLC, Woburn, MA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
G01N 33/57555 (2026.01); G16B 20/00 (2019.01); G16B 25/10 (2019.01); G16H 10/40 (2018.01); G16H 50/20 (2018.01); G16H 50/30 (2018.01);
U.S. Cl.
CPC ...
G01N 33/57555 (2026.01); G16B 20/00 (2019.02); G16B 25/10 (2019.02); G16H 10/40 (2018.01); G16H 50/20 (2018.01); G16H 50/30 (2018.01); G01N 2333/96433 (2013.01); G01N 2333/96455 (2013.01);
Abstract

Improved methods and systems for active surveillance are generally described. For example, methods comprising subjecting the blood sample of the subject to one or more immunoassays that measure levels of kallikrein markers comprising free prostate specific antigen (fPSA), intact prostate specific antigen (iPSA), total prostate specific antigen (tPSA) and human kallikrein 2 (hK2); and determining the probability that a prostate tissue biopsy obtained from the subject would contain detectable aggressive prostate cancer using a logistic regression model with aggressive prostate cancer as the outcome are described.


Find Patent Forward Citations

Dong, Yan. (2026). Systems for providing a probability of prostate cancer risk and/or prostate gland volume, and related methods (U.S. Patent No. 12656348). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12656348

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…